Physician

Charles K Newell, M.D.

According to 2025 Medicare claims, Charles Newell, M.D. (NPI: 1245298223) practices ophthalmology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is SOUTHERN VITREORETINAL ASSOCIATES, PL (NPI: 1871665448; TIN: 208515285) and primary practice location at 31707-0209.

Newell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 664 traditional Medicare patients, billed 33,717 HCPCS/CPT codes, and received $2,232,698 in Medicare payments. The top billing code was J2778 (Injection, ranibizumab, 0.1 mg). Part D data shows 403 prescription claims across 149 beneficiaries totaling $15,622 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 11 records totaling $224. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $34,487 to $15,622. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	890	11,992	$2,377,177
2016	1,064	15,856	$3,200,563
2017	1,121	17,104	$3,424,526
2018	1,032	17,920	$3,633,003
2019	940	15,884	$3,268,715
2020	755	13,474	$2,856,952
2021	755	13,922	$2,958,072
2022	679	12,508	$2,754,607
2023	683	23,197	$2,615,836
2024	664	33,717	$2,232,698

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	195	662	$34,487
2016	228	732	$30,515
2017	217	696	$30,276
2018	192	653	$30,790
2019	173	518	$32,998
2020	163	539	$23,921
2021	200	488	$22,068
2022	154	402	$15,412
2023	178	456	$25,838
2024	149	403	$15,622

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J2778	Injection, ranibizumab, 0.1 mg	157	3,858	$124
67028	Injection of drug into eye	331	1,669	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	154	192	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	187	244	$61
92134	Imaging of retina	527	1,844	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	198	6,006	$8,906
Ketorolac Tromethamine	Ketorolac Tromethamine	55	1,331	$1,488
Moxifloxacin	Moxifloxacin Hcl	16	271	$934
Polymyxin B Sul-Trimethoprim	Polymyxin B Sulf/Trimethoprim	85	3,195	$630

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$224	Apellis Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$280,063	US Retina LLC

Explore More Providers

FAQ

What Medicare data is available for Charles K. Newell, M.D.?

Tedicare shows public-source Medicare data for Charles K. Newell, M.D. (NPI 1245298223), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles K. Newell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles K. Newell, M.D.?

Charles K. Newell, M.D. is linked to SOUTHERN VITREORETINAL ASSOCIATES, PL (billing NPI 1871665448) in the available physician profile data.

Does Charles K. Newell, M.D. have Open Payments data?

Charles K. Newell, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.